McKesson (McKesson) Change In Payables And Accrued Expense

: $4,420 Mil (TTM As of Dec. 2023)

View and export this data going back to 1987. Start your Free Trial

McKesson's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was $-144 Mil. It means McKesson's Accounts Payable & Accrued Expense declined by $144 Mil from Sep. 2023 to Dec. 2023 .

McKesson's Change In Payables And Accrued Expense for the fiscal year that ended in Mar. 2023 was $3,788 Mil. It means McKesson's Accounts Payable & Accrued Expense increased by $3,788 Mil from Mar. 2022 to Mar. 2023 .

McKesson Change In Payables And Accrued Expense Historical Data

The historical data trend for McKesson's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

McKesson Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Change In Payables And Accrued Expense

1,976.00

3,952.00

1,267.00

2,802.00

3,788.00

McKesson Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Payables And Accrued Expense																1,239.00	257.00	1,473.00	2,834.00	-144.00

McKesson Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $4,420 Mil.

McKesson Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of McKesson's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

McKesson (McKesson) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » McKesson Corp (NYSE:MCK) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

MCK:Germany MCK:Germany M1CK34:Brazil

Address

6555 State Highway 161, Irving, TX, USA, 75039

Website

https://www.mckesson.com

McKesson Corp is one of three leading pharmaceutical wholesalers in the U.S. engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the U.S. pharmaceutical wholesale industry. Outside the U.S. market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Executives

Brian S. Tyler	officer: Chief Executive Officer	MCKESSON CORPORATION, 6555 STATE HWY 161, IRVING TX 75039
Leann B Smith	officer: EVP & Chief HR Officer	6555 NORTH STATE HWY 161, IRVING TX 75039
Thomas L Rodgers	officer: EVP, Chief Strategy & BDO	6555 NORTH STATE HWY 161, IRVING TX 75039
Lori A. Schechter	officer: EVP, Chief Legal Officer & GC	MCKESSON CORPORATION, 6555 NORTH STATE HWY 161, IRVING TX 75039
Nancy Flores	officer: EVP, CIO & CTO	6555 NORTH STATE HWY 161, IRVING TX 75039
Britt J. Vitalone	officer: EVP & CFO	MCKESSON CORPORATION, 6555 STATE HWY 161, IRVING TX 75039
Tracy Faber	officer: EVP & Chief HR Officer	6555 NORTH STATE HWY 161, IRVING TX 75039
Maria Martinez	director	THE LANDMARK @ 1 MARKET STREET, SUITE 300, SAN FRANCISCO CA 94105
Susan Nowakowski	director	14778 EL RODEO CT., RANCHO SANTA FE CA 92067
Dominic J Caruso	director	JOHNSON & JOHNSON, ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933
Donald R Knauss	director	P O BOX 1734, ATLANTA GA 30301
Bradley E Lerman	director	MEDTRONIC, INC., 710 MEDTRONIC PKWY MSLC300, MINNEAPOLIS MN 55432
Webster Roy Dunbar	director	5757 N. GREEN BAY AVENUE, MILWAUKEE WI 53209
Rutledge Napoleon B Jr	officer: SVP, Controller & CAO	2999 WILDWOOD PARKWAY, ATLANTA GA 30339
Kathleen Wilson-thompson	director	PO BOX 3599, BATTLE CREEK MI 49016-3599